AAP
XENT

Ardsley Advisory Partners’s Intersect ENT, Inc XENT Stock Holding History

Ardsley Advisory Partners’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-15,000
Closed -$387K – 247
2015
Q1 		$387K Buy
+15,000
New +$343K 0.05% 136

Other funds holding XENT

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
NVPX
Norwest Venture Partners XI Palo Alto, California $32.1M AUM 15.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Ardsley Advisory Partners's XENT Position: Q2 2015 in Review

Ardsley Advisory Partners sold out of Intersect ENT, Inc (XENT) in Q2 2015, closing a stake of 15,000 shares — an estimated $387K sold.

Ardsley Advisory Partners first reported a position in XENT in Q1 2015 and held it in 1 quarter. The position peaked at $387K in Q1 2015. 128 funds tracked by Wall St. Rank hold XENT as of Q2 2015.

  • Ardsley Advisory Partners reported no remaining Intersect ENT, Inc position as of Q2 2015 after selling out during the quarter.
  • Ardsley Advisory Partners sold 15,000 Intersect ENT, Inc shares in Q2 2015, an estimated $387K.
  • Ardsley Advisory Partners first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 1 quarter.
  • Ardsley Advisory Partners's Intersect ENT, Inc position peaked at $387K in Q1 2015.
  • 128 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2015.

Based on Ardsley Advisory Partners's 13F filing for Q2 2015, filed 14 Aug 2015.